Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an intravenous formulation for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, urinary tract infections, meningitis, sepsis, and hospital‑acquired pneumonia in hospitalized patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections that are resistant to other agents.

- Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens, helping resolve infection. - Complicated urinary tract infections: eradicates resistant Gram‑negative organisms, leading to clinical cure. - Bacterial meningitis: achieves cerebrospinal fluid concentrations sufficient to treat susceptible pathogens. - Severe sepsis and septic shock: offers rapid bacterial clearance to support hemodynamic stabilization. - Hospital‑acquired pneumonia: targets multidrug‑resistant organisms commonly implicated in nosocomial lung infections.

Adverse reactions may occur with meropenem therapy and are categorized by frequency.

Common Side Effects: - Diarrhea - Nausea - Vomiting - Rash or pruritus - Elevated liver enzymes - Headache

Serious or Rare Side Effects: - Seizures, especially in patients with CNS disorders or high doses - Clostridioides difficile‑associated colitis - Anaphylactic or severe hypersensitivity reactions - Acute renal impairment - Neutropenia or agranulocytosis - Thrombocytopenia

Before initiating therapy, clinicians should consider several safety aspects.

- Renal function: adjust dose in patients with impaired renal clearance. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or other β‑lactams. - Seizure risk: monitor patients with pre‑existing CNS disorders or receiving high doses. - Pregnancy and lactation: use only when the potential benefit justifies the potential risk to the fetus or infant. - Drug interactions: review concomitant medications for possible interactions. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Valproic acid: meropenem can lower serum valproate levels, risking seizure breakthrough. - Probenecid: may increase meropenem plasma concentrations, heightening toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: may enhance ototoxic potential when combined with other ototoxic agents. - Anticoagulants (e.g., warfarin): may increase INR; monitor coagulation parameters.